ラット・マウスモデル市場規模、シェア、動向分析レポート:モデル・サービス別、用途別(心血管疾患、遺伝子疾患)、最終用途別(製薬・バイオ企業)、地域別、セグメント別予測、2024年~2030年Rat And Mouse Model Market Size, Share & Trends Analysis Report By Model And Services, By Application (Cardiovascular Diseases, Genetic Diseases), By End-use (Pharmaceutical & Biotechnology Companies), By Region, And Segment Forecasts, 2024 - 2030 ラット・マウスモデル市場の成長と動向 Grand View Research社の最新レポートによると、世界のラット・マウスモデル市場は2030年までに35億8000万米ドルに達すると予測され、2024年から2030年までのCAGRは9.0... もっと見る
1~3営業日
サマリーラット・マウスモデル市場の成長と動向Grand View Research社の最新レポートによると、世界のラット・マウスモデル市場は2030年までに35億8000万米ドルに達すると予測され、2024年から2030年までのCAGRは9.0%で拡大すると予測されている。ヒト化マウスやラットモデルは、ヒトの遺伝子、組織、細胞、臓器が機能するため、生物学的研究や医学的研究に使用されている。健康や臨床の場では、これらのマウスやラットのプロトタイプはヒトの免疫系を再現するために利用される。さらに、ヒト化マウス・ラットプロトタイプは、基礎研究、高分子医薬品の安全性評価、ヒト特異的感染症のシミュレーション、免疫療法アプローチの有効性試験などにも使用されています。 免疫不全疾患、腫瘍、その他様々な希少疾患の同定にマウス・ラットプロトタイプを使用すること、ヘルスケア企業やバイオテクノロジー企業による研究開発活動の増加、マウス・ラットモデル研究に対する政府や民間部門からの継続的な資金提供や介入が、世界市場を牽引している。さらに、動物モデル開発のための技術的進歩が市場成長を促進すると予想されている。企業は、より優れたモデルを開発するために先進技術を採用している。例えば、2023年10月、同業界の大手企業であるTaconic Biosciences社は、マウスモデルの開発と製造を促進できるExprssMODEL CRISPRプラットフォームを発表した。このプラットフォームは、拡大繁殖のステップを不要にし、研究全体のタイムラインを最低3カ月短縮することができる。このような開発は、予測期間中の業界の成長を促進すると予想される。 さらに、この業界で事業を展開する企業は、市場での地位を強化するために、提携、共同研究、買収、合併など、いくつかの取り組みを行っている。例えば、2023年4月、カスタム遺伝子改変ラット、マウス、ウサギモデルのプロバイダーであるingenious targeting laboratory社は、Shanghai Model Organisms Center(SMOC)と提携し、SMOCの検証済み既製マウスモデルを欧州と北米で販売することになった。このような提携により、動物モデルへのアクセスが向上し、今後数年間の市場成長を促進することが期待される。 ラット・マウスモデル市場レポートハイライト - モデル分野は、さまざまな種類のラットや動物モデルが入手可能であることから、2023年の売上高シェア88.6%でモデル・サービス分野を支配した。 - 凍結保存、繁殖、検証、表現型解析、飼育、再活性化など数多くのサービスを提供することに業界参加者が注力するようになっているため、サービス分野は予測期間中に最も速いCAGRで成長する見込みである。 - 用途別では、がん分野が2023年の市場を支配した。一方、遺伝病セグメントは予測期間中に最も速い成長を目撃すると予想されている。 - 北米地域は、Inotiv、Charles River Laboratories、Ozgene Pty Ltd、Taconic Biosciencesのような主要市場プレイヤーの存在や、同地域の製薬・研究分野の成長などの要因により、市場を支配している。 - アジア太平洋地域は、日本のようなアジア太平洋諸国でのプレゼンスを拡大する複数の企業により、予測期間中に最も速い成長を記録すると予想されている。 - 世界のラット・マウスモデル市場で事業を展開している主な市場参入企業には、Charles River Laboratories、The Jackson Laboratory、Cyagen、genOway、Inotiv、Janvier Labs、Taconic Biosciences, Inc、Biomedical Research Models (Biomere)、Hera Biolabs、Kind Lab、Ozgene Pty Ltdなどがある。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Model and Service 1.2.2. Application 1.2.3. End-use 1.2.4. Regional scope 1.2.5. Estimates and forecasts timeline 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased database 1.4.2. GVR’s internal database 1.4.3. Secondary sources 1.4.4. Primary research 1.4.5. Details of primary research 1.4.5.1. Data for Primary Interviews in North America 1.4.5.2. Data for primary interviews in Europe 1.4.5.3. Data for primary interviews in Asia Pacific 1.4.5.4. Data for Primary Interviews in Latin America 1.4.5.5. Data for Primary Interviews in MEA 1.5. Information or Data Analysis 1.5.1. Data analysis models 1.6. Market Formulation & Validation 1.7. Model Details 1.7.1. Commodity flow analysis (Model 1) 1.7.2. Approach 1: Commodity flow approach 1.7.3. Volume price analysis (Model 2) 1.7.4. Approach 2: Volume price analysis 1.8. List of Secondary Sources 1.9. List of Primary Sources 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Model and Service Outlook 2.2.2. End-use outlook 2.2.3. Application outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Rat and Mouse Model Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Rise in adoption of personalized & precision medicine and increasing demand of rat & mouse models. 3.2.1.2. Application of genome editing tools for generation of rodent models 3.2.1.3. Increase in the number of research activities involving the use of rat and mouse models. 3.2.2. Market restraint analysis 3.2.2.1. Ethical issues pertaining to the use of animals for research. 3.2.2.2. Rise in adoption of alternative animal models for biomedical research 3.3. Rat and Mouse Model Market Analysis Tools 3.3.1. Industry Analysis - Porter’s 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis 3.3.2.1. Political landscape 3.3.2.2. Technological landscape 3.3.2.3. Economic Landscape 3.3.3. COVID-19 Impact Analysis Chapter 4. Rat and Mouse Model Market: Model and Service Estimates & Trend Analysis 4.1. Model and Service Market Share, 2023 & 2030 4.2. Segment Dashboard 4.3. Global Rat and Mouse Model Market by Model and Service Outlook 4.4. Model & Service Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following 4.4.1. Model 4.4.1.1. Model Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.2. Inbred 4.4.1.2.1. Inbred Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.2.2. Knockout 4.4.1.2.2.1. Knockout Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.2.3. Knock-in 4.4.1.2.3.1. Knock-in Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.2.4. Others 4.4.1.2.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.3. Outbred 4.4.1.3.1. Outbred Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.3.2. Knockout 4.4.1.3.2.1. Knockout Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.3.3. Knock-in 4.4.1.3.3.1. Knock-in Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.3.4. Others 4.4.1.3.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2. Service 4.4.2.1. Service Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.2. Cryopreservation 4.4.2.2.1. Cryopreservation Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.3. Breeding 4.4.2.3.1. Breeding Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.4. Rederivation 4.4.2.4.1. Rederivation Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.5. Genetic Testing 4.4.2.5.1. Genetic Testing Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.6. Quarantine Depending 4.4.2.6.1. Quarantine Depending Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.7. Others 4.4.2.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 5. Rat and Mouse Model Market: Application Estimates & Trend Analysis 5.1. Application Market Share, 2023 & 2030 5.2. Segment Dashboard 5.3. Global Rat and Mouse Model Market by Application Outlook 5.4. Application Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following 5.4.1. Application Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.2. Cardiovascular diseases 5.4.2.1. Cardiovascular Diseases Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.3. Genetic Diseases 5.4.3.1. Genetic Diseases Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.4. Cancer 5.4.4.1. Cancer Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.5. Infectious Diseases 5.4.5.1. Infectious Diseases Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.5.1.1. COVID-19 5.4.5.1.1.1. COVID-19 Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.5.1.2. Others 5.4.5.1.2.1. Others Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.6. Transplantation 5.4.6.1. Transplantation Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.7. Others 5.4.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 6. Rat and Mouse Model Market: End-use Estimates & Trend Analysis 6.1. End-use Market Share, 2023 & 2030 6.2. Segment Dashboard 6.3. Global Rat and Mouse Model Market by End-use Outlook 6.4. End-use Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following 6.4.1. Pharmaceutical & Biotechnology companies 6.4.1.1. Pharmaceutical & Biotechnology Companies Market estimates and forecasts 2018 to 2030 (USD million) 6.4.2. Academic and Research Facilities 6.4.2.1. Academic and Research Facilities Market estimates and forecasts 2018 to 2030 (USD Million) 6.4.3. Contract Research & Manufacturing Organizations 6.4.3.1. Contract Research & Manufacturing Organizations Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 7. Rat and Mouse Model Market: Regional Estimates & Trend Analysis 7.1. Regional Market Share Analysis, 2023 & 2030 7.2. Regional Market Dashboard 7.3. Global Regional Market Snapshot 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030 7.5. North America 7.5.1. U.S. 7.5.1.1. Key country dynamics 7.5.1.2. Regulatory framework 7.5.1.3. Competitive scenario 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) 7.5.2. Canada 7.5.2.1. Key country dynamics 7.5.2.2. Regulatory framework 7.5.2.3. Competitive scenario 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) 7.6. Europe 7.6.1. UK 7.6.1.1. Key country dynamics 7.6.1.2. Regulatory framework 7.6.1.3. Competitive scenario 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) 7.6.2. Germany 7.6.2.1. Key country dynamics 7.6.2.2. Regulatory framework 7.6.2.3. Competitive scenario 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) 7.6.3. France 7.6.3.1. Key country dynamics 7.6.3.2. Regulatory framework 7.6.3.3. Competitive scenario 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) 7.6.4. Italy 7.6.4.1. Key country dynamics 7.6.4.2. Regulatory framework 7.6.4.3. Competitive scenario 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) 7.6.5. Spain 7.6.5.1. Key country dynamics 7.6.5.2. Regulatory framework 7.6.5.3. Competitive scenario 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) 7.6.6. Norway 7.6.6.1. Key country dynamics 7.6.6.2. Regulatory framework 7.6.6.3. Competitive scenario 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) 7.6.7. Sweden 7.6.7.1. Key country dynamics 7.6.7.2. Regulatory framework 7.6.7.3. Competitive scenario 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) 7.6.8. Denmark 7.6.8.1. Key country dynamics 7.6.8.2. Regulatory framework 7.6.8.3. Competitive scenario 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) 7.7. Asia Pacific 7.7.1. Japan 7.7.1.1. Key country dynamics 7.7.1.2. Regulatory framework 7.7.1.3. Competitive scenario 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) 7.7.2. China 7.7.2.1. Key Country Dynamics 7.7.2.2. Regulatory framework 7.7.2.3. Competitive scenario 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) 7.7.3. India 7.7.3.1. Key country dynamics 7.7.3.2. Regulatory framework 7.7.3.3. Competitive scenario 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) 7.7.4. Australia 7.7.4.1. Key country dynamics 7.7.4.2. Regulatory framework 7.7.4.3. Competitive scenario 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) 7.7.5. South Korea 7.7.5.1. Key country dynamics 7.7.5.2. Regulatory framework 7.7.5.3. Competitive scenario 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) 7.7.6. Thailand 7.7.6.1. Key country dynamics 7.7.6.2. Regulatory framework 7.7.6.3. Competitive scenario 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) 7.8. Latin America 7.8.1. Brazil 7.8.1.1. Key country dynamics 7.8.1.2. Regulatory framework 7.8.1.3. Competitive scenario 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) 7.8.2. Mexico 7.8.2.1. Key country dynamics 7.8.2.2. Regulatory framework 7.8.2.3. Competitive scenario 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) 7.8.3. Argentina 7.8.3.1. Key country dynamics 7.8.3.2. Regulatory framework 7.8.3.3. Competitive scenario 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) 7.9. MEA 7.9.1. South Africa 7.9.1.1. Key country dynamics 7.9.1.2. Regulatory framework 7.9.1.3. Competitive scenario 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) 7.9.2. Saudi Arabia 7.9.2.1. Key country dynamics 7.9.2.2. Regulatory framework 7.9.2.3. Competitive scenario 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) 7.9.3. UAE 7.9.3.1. Key country dynamics 7.9.3.2. Regulatory framework 7.9.3.3. Competitive scenario 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) 7.9.4. Kuwait 7.9.4.1. Key country dynamics 7.9.4.2. Regulatory framework 7.9.4.3. Competitive scenario 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Company/Competition Categorization 8.3. Vendor Landscape 8.3.1. List of key distributors and channel partners 8.3.2. Key customers 8.3.3. Key company market share analysis, 2023 8.3.4. Charles River Laboratories 8.3.4.1. Company overview 8.3.4.2. Financial performance 8.3.4.3. Product benchmarking 8.3.4.4. Strategic initiatives 8.3.5. The Jackson Laboratory 8.3.5.1. Company overview 8.3.5.2. Financial performance 8.3.5.3. Product benchmarking 8.3.5.4. Strategic initiatives 8.3.6. Cyagen 8.3.6.1. Company overview 8.3.6.2. Financial performance 8.3.6.3. Product benchmarking 8.3.6.4. Strategic initiatives 8.3.7. genOway 8.3.7.1. Company overview 8.3.7.2. Financial performance 8.3.7.3. Product benchmarking 8.3.7.4. Strategic initiatives 8.3.8. Inotiv 8.3.8.1. Company overview 8.3.8.2. Financial performance 8.3.8.3. Product benchmarking 8.3.8.4. Strategic initiatives 8.3.9. Janvier Labs 8.3.9.1. Company overview 8.3.9.2. Financial performance 8.3.9.3. Product benchmarking 8.3.9.4. Strategic initiatives 8.3.10. Taconic Biosciences, Inc. 8.3.10.1. Company overview 8.3.10.2. Financial performance 8.3.10.3. Product benchmarking 8.3.10.4. Strategic initiatives 8.3.11. Biomedical Research Models (Biomere) 8.3.11.1. Company overview 8.3.11.2. Financial performance 8.3.11.3. Product benchmarking 8.3.11.4. Strategic initiatives 8.3.12. Hera Biolabs 8.3.12.1. Company overview 8.3.12.2. Financial performance 8.3.12.3. Product benchmarking 8.3.12.4. Strategic initiatives 8.3.13. Kind Lab 8.3.13.1. Company overview 8.3.13.2. Financial performance 8.3.13.3. Product benchmarking 8.3.13.4. Strategic initiatives 8.3.14. Ozgene Pty Ltd 8.3.14.1. Company overview 8.3.14.2. Financial performance 8.3.14.3. Product benchmarking 8.3.14.4. Strategic initiatives
SummaryRat And Mouse Model Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Model and Service 1.2.2. Application 1.2.3. End-use 1.2.4. Regional scope 1.2.5. Estimates and forecasts timeline 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased database 1.4.2. GVR’s internal database 1.4.3. Secondary sources 1.4.4. Primary research 1.4.5. Details of primary research 1.4.5.1. Data for Primary Interviews in North America 1.4.5.2. Data for primary interviews in Europe 1.4.5.3. Data for primary interviews in Asia Pacific 1.4.5.4. Data for Primary Interviews in Latin America 1.4.5.5. Data for Primary Interviews in MEA 1.5. Information or Data Analysis 1.5.1. Data analysis models 1.6. Market Formulation & Validation 1.7. Model Details 1.7.1. Commodity flow analysis (Model 1) 1.7.2. Approach 1: Commodity flow approach 1.7.3. Volume price analysis (Model 2) 1.7.4. Approach 2: Volume price analysis 1.8. List of Secondary Sources 1.9. List of Primary Sources 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Model and Service Outlook 2.2.2. End-use outlook 2.2.3. Application outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Rat and Mouse Model Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Rise in adoption of personalized & precision medicine and increasing demand of rat & mouse models. 3.2.1.2. Application of genome editing tools for generation of rodent models 3.2.1.3. Increase in the number of research activities involving the use of rat and mouse models. 3.2.2. Market restraint analysis 3.2.2.1. Ethical issues pertaining to the use of animals for research. 3.2.2.2. Rise in adoption of alternative animal models for biomedical research 3.3. Rat and Mouse Model Market Analysis Tools 3.3.1. Industry Analysis - Porter’s 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis 3.3.2.1. Political landscape 3.3.2.2. Technological landscape 3.3.2.3. Economic Landscape 3.3.3. COVID-19 Impact Analysis Chapter 4. Rat and Mouse Model Market: Model and Service Estimates & Trend Analysis 4.1. Model and Service Market Share, 2023 & 2030 4.2. Segment Dashboard 4.3. Global Rat and Mouse Model Market by Model and Service Outlook 4.4. Model & Service Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following 4.4.1. Model 4.4.1.1. Model Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.2. Inbred 4.4.1.2.1. Inbred Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.2.2. Knockout 4.4.1.2.2.1. Knockout Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.2.3. Knock-in 4.4.1.2.3.1. Knock-in Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.2.4. Others 4.4.1.2.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.3. Outbred 4.4.1.3.1. Outbred Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.3.2. Knockout 4.4.1.3.2.1. Knockout Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.3.3. Knock-in 4.4.1.3.3.1. Knock-in Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.1.3.4. Others 4.4.1.3.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2. Service 4.4.2.1. Service Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.2. Cryopreservation 4.4.2.2.1. Cryopreservation Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.3. Breeding 4.4.2.3.1. Breeding Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.4. Rederivation 4.4.2.4.1. Rederivation Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.5. Genetic Testing 4.4.2.5.1. Genetic Testing Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.6. Quarantine Depending 4.4.2.6.1. Quarantine Depending Market estimates and forecasts 2018 to 2030 (USD Million) 4.4.2.7. Others 4.4.2.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 5. Rat and Mouse Model Market: Application Estimates & Trend Analysis 5.1. Application Market Share, 2023 & 2030 5.2. Segment Dashboard 5.3. Global Rat and Mouse Model Market by Application Outlook 5.4. Application Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following 5.4.1. Application Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.2. Cardiovascular diseases 5.4.2.1. Cardiovascular Diseases Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.3. Genetic Diseases 5.4.3.1. Genetic Diseases Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.4. Cancer 5.4.4.1. Cancer Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.5. Infectious Diseases 5.4.5.1. Infectious Diseases Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.5.1.1. COVID-19 5.4.5.1.1.1. COVID-19 Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.5.1.2. Others 5.4.5.1.2.1. Others Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.6. Transplantation 5.4.6.1. Transplantation Market estimates and forecasts 2018 to 2030 (USD Million) 5.4.7. Others 5.4.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 6. Rat and Mouse Model Market: End-use Estimates & Trend Analysis 6.1. End-use Market Share, 2023 & 2030 6.2. Segment Dashboard 6.3. Global Rat and Mouse Model Market by End-use Outlook 6.4. End-use Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following 6.4.1. Pharmaceutical & Biotechnology companies 6.4.1.1. Pharmaceutical & Biotechnology Companies Market estimates and forecasts 2018 to 2030 (USD million) 6.4.2. Academic and Research Facilities 6.4.2.1. Academic and Research Facilities Market estimates and forecasts 2018 to 2030 (USD Million) 6.4.3. Contract Research & Manufacturing Organizations 6.4.3.1. Contract Research & Manufacturing Organizations Market estimates and forecasts 2018 to 2030 (USD Million) Chapter 7. Rat and Mouse Model Market: Regional Estimates & Trend Analysis 7.1. Regional Market Share Analysis, 2023 & 2030 7.2. Regional Market Dashboard 7.3. Global Regional Market Snapshot 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030 7.5. North America 7.5.1. U.S. 7.5.1.1. Key country dynamics 7.5.1.2. Regulatory framework 7.5.1.3. Competitive scenario 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) 7.5.2. Canada 7.5.2.1. Key country dynamics 7.5.2.2. Regulatory framework 7.5.2.3. Competitive scenario 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) 7.6. Europe 7.6.1. UK 7.6.1.1. Key country dynamics 7.6.1.2. Regulatory framework 7.6.1.3. Competitive scenario 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) 7.6.2. Germany 7.6.2.1. Key country dynamics 7.6.2.2. Regulatory framework 7.6.2.3. Competitive scenario 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) 7.6.3. France 7.6.3.1. Key country dynamics 7.6.3.2. Regulatory framework 7.6.3.3. Competitive scenario 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) 7.6.4. Italy 7.6.4.1. Key country dynamics 7.6.4.2. Regulatory framework 7.6.4.3. Competitive scenario 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) 7.6.5. Spain 7.6.5.1. Key country dynamics 7.6.5.2. Regulatory framework 7.6.5.3. Competitive scenario 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) 7.6.6. Norway 7.6.6.1. Key country dynamics 7.6.6.2. Regulatory framework 7.6.6.3. Competitive scenario 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) 7.6.7. Sweden 7.6.7.1. Key country dynamics 7.6.7.2. Regulatory framework 7.6.7.3. Competitive scenario 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) 7.6.8. Denmark 7.6.8.1. Key country dynamics 7.6.8.2. Regulatory framework 7.6.8.3. Competitive scenario 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) 7.7. Asia Pacific 7.7.1. Japan 7.7.1.1. Key country dynamics 7.7.1.2. Regulatory framework 7.7.1.3. Competitive scenario 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) 7.7.2. China 7.7.2.1. Key Country Dynamics 7.7.2.2. Regulatory framework 7.7.2.3. Competitive scenario 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) 7.7.3. India 7.7.3.1. Key country dynamics 7.7.3.2. Regulatory framework 7.7.3.3. Competitive scenario 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) 7.7.4. Australia 7.7.4.1. Key country dynamics 7.7.4.2. Regulatory framework 7.7.4.3. Competitive scenario 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) 7.7.5. South Korea 7.7.5.1. Key country dynamics 7.7.5.2. Regulatory framework 7.7.5.3. Competitive scenario 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) 7.7.6. Thailand 7.7.6.1. Key country dynamics 7.7.6.2. Regulatory framework 7.7.6.3. Competitive scenario 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) 7.8. Latin America 7.8.1. Brazil 7.8.1.1. Key country dynamics 7.8.1.2. Regulatory framework 7.8.1.3. Competitive scenario 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) 7.8.2. Mexico 7.8.2.1. Key country dynamics 7.8.2.2. Regulatory framework 7.8.2.3. Competitive scenario 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) 7.8.3. Argentina 7.8.3.1. Key country dynamics 7.8.3.2. Regulatory framework 7.8.3.3. Competitive scenario 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) 7.9. MEA 7.9.1. South Africa 7.9.1.1. Key country dynamics 7.9.1.2. Regulatory framework 7.9.1.3. Competitive scenario 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) 7.9.2. Saudi Arabia 7.9.2.1. Key country dynamics 7.9.2.2. Regulatory framework 7.9.2.3. Competitive scenario 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) 7.9.3. UAE 7.9.3.1. Key country dynamics 7.9.3.2. Regulatory framework 7.9.3.3. Competitive scenario 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) 7.9.4. Kuwait 7.9.4.1. Key country dynamics 7.9.4.2. Regulatory framework 7.9.4.3. Competitive scenario 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Company/Competition Categorization 8.3. Vendor Landscape 8.3.1. List of key distributors and channel partners 8.3.2. Key customers 8.3.3. Key company market share analysis, 2023 8.3.4. Charles River Laboratories 8.3.4.1. Company overview 8.3.4.2. Financial performance 8.3.4.3. Product benchmarking 8.3.4.4. Strategic initiatives 8.3.5. The Jackson Laboratory 8.3.5.1. Company overview 8.3.5.2. Financial performance 8.3.5.3. Product benchmarking 8.3.5.4. Strategic initiatives 8.3.6. Cyagen 8.3.6.1. Company overview 8.3.6.2. Financial performance 8.3.6.3. Product benchmarking 8.3.6.4. Strategic initiatives 8.3.7. genOway 8.3.7.1. Company overview 8.3.7.2. Financial performance 8.3.7.3. Product benchmarking 8.3.7.4. Strategic initiatives 8.3.8. Inotiv 8.3.8.1. Company overview 8.3.8.2. Financial performance 8.3.8.3. Product benchmarking 8.3.8.4. Strategic initiatives 8.3.9. Janvier Labs 8.3.9.1. Company overview 8.3.9.2. Financial performance 8.3.9.3. Product benchmarking 8.3.9.4. Strategic initiatives 8.3.10. Taconic Biosciences, Inc. 8.3.10.1. Company overview 8.3.10.2. Financial performance 8.3.10.3. Product benchmarking 8.3.10.4. Strategic initiatives 8.3.11. Biomedical Research Models (Biomere) 8.3.11.1. Company overview 8.3.11.2. Financial performance 8.3.11.3. Product benchmarking 8.3.11.4. Strategic initiatives 8.3.12. Hera Biolabs 8.3.12.1. Company overview 8.3.12.2. Financial performance 8.3.12.3. Product benchmarking 8.3.12.4. Strategic initiatives 8.3.13. Kind Lab 8.3.13.1. Company overview 8.3.13.2. Financial performance 8.3.13.3. Product benchmarking 8.3.13.4. Strategic initiatives 8.3.14. Ozgene Pty Ltd 8.3.14.1. Company overview 8.3.14.2. Financial performance 8.3.14.3. Product benchmarking 8.3.14.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
Grand View Research社の生物分野での最新刊レポート
本レポートと同じKEY WORD(cardiovascular)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/23 10:26 157.72 円 164.94 円 201.11 円 |